Prostate Cancer

Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy. December 19, 2022

Chromogranin A: a useful biomarker in castration-resistant prostate cancer. December 19, 2022

Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. December 19, 2022

Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention. December 19, 2022

Salvage irreversible electroporation for radio recurrent prostate cancer - The prospective FIRE trial. December 16, 2022

Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant pros December 16, 2022

What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer? December 16, 2022

Detection of prostate cancer bone metastases with fast whole-body 99mTc-HMDP SPECT/CT using a general-purpose CZT system. December 16, 2022

PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration. December 16, 2022

Update on US Regulatory Priority Review of Lynparza in Combination with Abiraterone in Metastatic Castration-Resistant Prostate Cancer December 15, 2022

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy. December 15, 2022

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study. December 15, 2022

The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer. December 15, 2022

Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group). December 15, 2022

Prospectively Accelerated T2-Weighted Imaging of the Prostate by Combining Compressed SENSE and Deep Learning in Patients with Histologically Proven Prostate Cancer. December 15, 2022

Women Play A Role in Prostate Health December 14, 2022

Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy. December 14, 2022

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis. December 14, 2022

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival? December 14, 2022

Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short? December 14, 2022

Page 10 of 1276

email news signup